News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research>G Sachs Upgrades JD HEALTH to Buy, Downgrades ALI HEALTH to Neutral
Goldman Sachs released a research report, considering that the online healthcare industry is benefiting from increased pharma penetration and policy support. It revisited its stock...
Reset
Send
The window will close in 5 seconds
<Research>G Sachs Upgrades JD HEALTH to Buy, Downgrades ALI HEALTH to Neutral
Close
Recommend
29
Positive
39
Negative
16
 
SHORT SELL
 
STOCK INFO

Goldman Sachs released a research report, considering that the online healthcare industry is benefiting from increased pharma penetration and policy support. It revisited its stock preference and upgraded JD HEALTH (06618.HK)  +0.050 (+0.126%)    Short selling $41.07M; Ratio 21.040%   to Buy from Neutral, and downgraded ALI HEALTH (00241.HK)  +0.010 (+0.231%)    Short selling $67.64M; Ratio 16.396%   to Neutral from Buy, reflecting the fact that JD HEALTH is better positioned than ALI HEALTH on the ride of prescription and OTC drugs, as well as online/offline integration. The broker raised its target price on JD HEALTH from $28 to $33.5 accordingly.

Goldman Sachs also raised its revenue and net profit forecasts on JD HEALTH for 2025 by 1% and 2026 by 2%. As for ALI HEALTH, its target price was trimmed to $4 from $4.4, and its revenue forecasts for 2024-26 were cut by 5%/ 7%/ 6%, while its net profit forecasts for 2025-26 were lowered by 7%/ 9%.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-06-20 16:25.)

AAStocks Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.